STUB1 and cancer: Unlike germline PVs, variants acquired somatically through CHIP do not carry hereditary cancer risk, though they are associated with other risks such as hematologic cancer, cardiovascular disease, and all‐cause mortality (Genovese et al., 2014; Gillis et al., 2017; Jaiswal et al., 2014; Jaiswal et al., 2017; Takahashi et al., 2017).